CELLPATH PLC – Trademark Portfolio

Entity Type: 03

CELLPATH PLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CELLPATH. The owner is based in Mid Wales.

Unit 66, Mochdre Enterprise Park

Newtown, Powys

Mid Wales SY16 4LE , GB

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CELLPATH
CELLPATH
Registered 2002
CELLSAFE
CELLSAFE
Cancelled 1993
CELLPATH
CELLPATH
Cancelled 1993

Trademark Classifications

CELLPATH PLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CELLPATH PLC have?

CELLPATH PLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does CELLPATH PLC file in?

CELLPATH PLC files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are CELLPATH PLC's most well-known trademarks?

CELLPATH PLC's registered trademark portfolio includes well-known marks such as CELLPATH. These are among 1 currently registered trademark in the portfolio.

What is CELLPATH PLC's trademark registration success rate?

CELLPATH PLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.